NFKB1 and amyotrophic lateral sclerosis: Increasing evidence indicates that NF-κB signaling influences the occurrence and progression of Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) through regulating the neuroimmunological response [3, 25–27].